2026 isn’t far off. Are your access priorities ready for the next wave of IRA-driven disruption?
Between Inflation Reduction Act (IRA) implementation milestones, global pricing pressures, and payer adoption of new contracting models, the next 18 months will redefine how access teams operate. The organizations that get ahead respond faster and navigate uncertainty with data-backed confidence.
eMAX Health Systems helps pharmaceutical and biotech leaders prepare with integrated insight, technology, and evidence tools that accelerate access readiness. Here are five key priorities shaping successful 2026 strategies..
1. IRA Readiness and Policy Simulation
Policy shifts are coming faster than guidance can catch up. Teams need to model the downstream effects of pricing negotiations, inflation caps, and formulary compression across portfolios.
How eMAX helps:
MAVA® and Elasticity™ model payer reactions, rebate scenarios, and price thresholds in real time to turn policy ambiguity into actionable strategy.
2. Contracting Agility
Static rebate frameworks won’t withstand evolving payer expectations. Access leaders must be ready to pivot toward outcomes-based, subscription, and hybrid models.
How eMAX helps:
The Contracting ROI module allows teams to evaluate rebate tradeoffs, model market share shifts, and quantify ROI before entering negotiations.
3. Real-World Data Integration
Evidence is no longer enough; context is everything. Linking EMR and claims data provides the proof payers require for coverage and value justification.
How eMAX helps:
EMRClaims+® combines 20M+ EMR records and national claims data to support HEOR, pricing, and policy analysis to enable faster validation of value narratives.
4. Continuous Advisory Engagement
Traditional advisory boards can’t keep pace with policy and payer evolution. Insight must be ongoing, iterative, and AI-assisted.
How eMAX helps:
Through MAVA’s blended human + AI moderation, manufacturers can engage validated payer and provider advisors continuously to collect real-time insight, not annual feedback.
5. Cross-Functional Launch Alignment
The most sophisticated insights mean little if they don’t reach Commercial, Medical, and HEOR teams in time to drive coordinated action.
How eMAX helps:
Our integrated analytics and insight workflows ensure findings move seamlessly from research to activation to close the gap between knowing and doing.
Looking Ahead
2026 will test every assumption about value, access, and evidence.
Manufacturers that build agility now will thrive as policy and payer landscapes continue to evolve.
At eMAX Health Systems, we’re partnering with access leaders to strengthen insight infrastructure, modernize evidence generation, and operationalize decision speed.
đź“© Ready to prepare your 2026 strategy?
Contact info@emaxhealth.net or visit emaxhealth.net to connect with our team.